A carregar...

Regional Variation in Use of a New Class of Antidiabetic Medication Among Medicare Beneficiaries: The Case of Incretin Mimetics

BACKGROUND: When incretin mimetic (IM) medications were introduced in 2005, their effectiveness compared other less-expensive second-line diabetes therapies was unknown, especially for older adults. Physicians likely had uncertainty about the role of IMs in the diabetes treatment armamentarium. Regi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Pharmacother
Main Authors: Marcum, Zachary A., Driessen, Julia, Thorpe, Carolyn T., Donohue, Julie M., Gellad, Walid F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876962/
https://ncbi.nlm.nih.gov/pubmed/25515869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1060028014563951
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!